Posts Tagged ‘Simvastatin’
Cholesterol lowering drugs linked to muscle injury
Written by Sadaka Associates
Wednesday, 05 November 2008 10:04
Our Simcor, Vytorin and Zocor injury lawyers are investigating claims of severe muscle injury with use of the cholesterol drugs. The injury is called rhabdomyolysis, which can lead to kidney failure or death, when simvastatin containing drugs like Simcor, Vytorin and Zocor are used with amiodarone, a medication used to treat irregular heart beat.
SIGNS & SYMPTOMS RHABDOMYOLYSIS
Rhabdomyolysis is the breakdown of muscle fibers resulting in the release of muscle fiber contents (myoglobin) into the bloodstream. Some of these are harmful to the kidney and frequently result in kidney damage.
Symptoms of Rhabdomyolysis
- Abnormal urine color (dark, red, or cola colored)
- General weakness
- Muscle stiffness or aching (myalgia)
- Muscle tenderness
- Weakness of the affected muscles
Additional symptoms that may be associated with this disease include the following:
- Fatigue
- Joint pain
- Seizures
- Weight gain (unintentional)
WHAT THE PUBLIC NEEDS TO KNOW ABOUT SIMVASTATIN RELATED RHABDOMYOLYSIS
- Amiodarone is used to control a heart rhythm problem and simvastatin is used to lower cholesterol.
- Simvastatin interacts with amiodarone and can cause a rare muscle injury condition called rhabdomyolysis. This condition can lead to kidney failure and possibly death.
- If you are taking amiodarone and a cholesterol-lowering drug product containing simvastatin, you should not take more than 20 mg of simvastatin each day because your risk of developing rhabdomyolysis increases.
- If you are starting therapy with simvastatin, or your dose of simvastatin is being increased, contact your doctor immediately if you experience symptoms of unexplained muscle injury, such as muscle cramps, pain, tenderness, stiffness or spasm.
CONTACT A SIMCOR, VYTORIN AND ZOCOR LAWYER NOW!
If you or a loved one suffered from a serious adverse reaction from the use of Simcor, Vytorin or Zocor, you have valuable legal rights. Please fill out our online form or call 1-866-311-2230 and a Simcor, Vytorin, and Zocor lawyer will contact you within 24 hours.
Profits Before People: Merck and Schering-Plough Caught Red handed
Written by Sadaka Associates
Tuesday, 01 April 2008 10:23
Emails between a Schering-Plough executive and the principle investigator of the ENHANCE trial were made public today by Sen. Chuck Grassley. The emails reveal that the ENHANCE trial’s principal investigator perceived that the drugmakers were withholding unfavorable results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons. (Surprise Surprise). Instead of releasing the bad data, Sen. Grassley noted, Merck/Schering-Plough went on a marketing blitz to increase Vytorin prescriptions.
For example, Grassley reported that Merck/Schering-Plough spent $3.5 million for the “49 plan,” a wine-and-dine marketing blitz of physicians to increase the volume of ezetimibe/simvastatin (Vytorin) prescriptions. He also chided the ACC for issuing a statement asking for calm and encouraging doctors to continue to prescribe Vytorin. That statement was passed to each member of congress by Merck/Schering-Plough.
Results
The full ENHANCE results were released at the American College of Cardiology (ACC) meeting here yesterday, two years after data collection ended. The study found that patients randomized to ezetimibe/simvastatin (Vytorin) had no significant benefit in atherosclerosis progression over simvastatin alone.
Contact Us | Vaginal Mesh Injury | Help for Gardasil Injury
Copying text from this site is prohibited by copyright law.
Please note that you are not considered a client until
you have signed a retainer agreement and your case has been accepted by us. Prior
results do not guarantee or predict a similar outcome with respect to any future matter.
ATTORNEY ADVERTISING
Law Offices of Sadaka Associates represents drug injury clients in drug injury lawsuits nationwide, including Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
We also serve the cities of New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose City, Detroit, Jacksonville, Indianapolis, San Francisco, Columbus, Austin, Memphis, Fort Worth, Baltimore, Charlotte, Boston, Seattle, Washington, Milwaukee, Denver, Louisville, Las Vegas, Nashville, Oklahoma City, Portland, Tucson, Albuquerque, Atlanta, Long Beach, Fresno, Sacramento, Mesa, Kansas City, Cleveland, Virginia Beach, Omaha, Miami, Oakland, Tulsa, Honolulu, Minneapolis, Colorado Springs, Arlington and Wichita.
__________________________________
Law Offices of Sadaka Associates LLC
20 North Van Brunt Street
Englewood, NJ 07631
Phone: 201-266-5670 Fax: 201-266-5671
